Navigation Links
Screening Proposed for Childhood Cholesterol Levels
Date:9/13/2007

Treatment would reduce risk of genetic condition that can lead to early death

THURSDAY, Sept. 13 (HealthDay News) -- A simple blood test early in life could identify children with familial hypercholesterolemia, a genetic condition that causes high cholesterol levels and greatly increases the risk of early death from heart disease, a British study finds.

Drug treatment could eventually be started to reduce that risk. And a side benefit could be identification of parents unaware that they were carrying the gene for the condition, the researchers said.

No elaborate genetic test would be needed, just a blood reading to find which children have abnormally high levels of LDL cholesterol -- the "bad" kind associated with blockage of arteries, said Dr. David Wald, lead author of the report.

The findings are published online Sept. 15 in the British Medical Journal.

An analysis of 13 studies that included 1,907 people with the condition showed that screening was most effective when done early in childhood, said Wald, a consultant cardiologist and senior lecturer at the Wolfson Institute of Preventive Medicine in London.

"The work we've done establishes the age at which screening performance is optimized," Wald said. He and his colleagues are planning "a limited implementation study that is necessary to establish feasibility," he said. The proposal is to include a cholesterol test at about 15 months of age, as part of a child's normal health-care routine.

Screening newborns or young adults was much less effective, the report said.

"Our study shows that a test would identify 88 percent of cases of familial hypercholesterolemia, with only one in 1,000 misidentified," Wald said.

The more common form of the condition, caused by a single gene, is estimated to occur in one of every 500 people in Great Britain and the United States. There are rare, much more severe cases of the disorder in which someone carries two faulty genes.

"It is the most important known and reversible cause of premature heart attack," Wald said. "It carries a 20- to 39-fold higher risk of dying of a heart attack before age 50."

The test proposed in the report would look for a blood LDL cholesterol level 1.5 times higher than the average for a child in the population being tested. "The first thing we would do then would be to test the parents," Wald said. "One of them would have to be affected, because it is a genetic condition. We could offer the parents immediate treatment."

Treatment for a parent or child carrying the gene would most likely be a cholesterol-lowering statin drug, he said.

A study reported last month by cardiologists at the University of Amsterdam in the Netherlands found that early long-term statin therapy prevented artery damage in children with familial hypercholesterolemia. The study included 214 children who were treated with statins for an average of 4.5 years.

The study participants ranged from 8 to 18 years old. The report described the results as "supporting the concept that statin treatment should be initiated in childhood." The study found "no adverse effects on sexual maturation or growth," the researchers added.

The British researchers "make a very reasonable case for screening" for familial hypercholesterolemia, said Dr. Steven Nissen, chairman of the department of cardiovascular medicine at the Cleveland Clinic. "I have a cluster of patients I follow, and I know you can give statins to children as young as 13," he added.

But the study alone "is not enough to change our current practice," Nissen said.

"The argument is that their lives would be shortened and the quality of life diminished" without screening, Nissen said. "But a decision about doing this in the United States must involve a lot more thinking and a lot more economic analysis, because it involves a huge screening program."

More information

For more on familial hypercholesterolemia, visit the U.S. National Library of Medicine.



SOURCES: David Wald, M.D., consultant cardiologist, Wolfson Institute of Preventive Medicine, London, England; Steven Nissen, M.D., chairman, department of cardiovascular medicine, Cleveland Clinic; Sept. 15, 2007, BMJ Online


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Need for Colon cancer screening
2. The Use Of MRI For Screening Of Breast Cancer Questioned
3. Early Screening For Cancer May Save Lives
4. Mobile Endoscopic Facilities For Health Screening
5. DNA biochip for genetic screening
6. Breast screening among diabetic women
7. Screening device for ovarian cancer
8. Fast screening for macular degeneration
9. Screening bypasses radical breast surgery
10. Screening of Lazy Eye
11. New virtual colonoscopy procedure for easier colon screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... ... 25, 2017 , ... Nissar A. Darmani, PhD, has been awarded a record ... chemotherapy-evoked nausea and vomiting. Dr. Darmani is Associate Dean of Basic Medical Sciences ... grant is from the National Cancer Institute (NCI) arm of the National Institutes of ...
(Date:9/25/2017)... ... September 25, 2017 , ... The Byron Eaton Agency, a Birmingham based ... region, is organizing a local charity drive to send money and support to families ... of water have fallen on Houston as a result of Hurricane Harvey, raising water ...
(Date:9/25/2017)... ... September 25, 2017 , ... Introducing Panther, the revolutionary new iPhone case ... platform Kickstarter seeking support for the #WarOnGrime. , Fact: iPhones are 18 ... shockingly revolting, yet true. The Panther iPhone cases are the first weapon in the ...
(Date:9/25/2017)... (PRWEB) , ... September 25, 2017 , ... ... , an international competition, were announced on Friday, September 22 during a gala ... the human resources professionals, teams, achievements and HR-related products and suppliers who help ...
(Date:9/25/2017)... ... 25, 2017 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that two of its leading biologics analytical experts will ... conferences. , At the BEBPA 10th Annual Bioassay Conference, to be held at ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... Sept. 7, 2017  For nearly two decades, New Life Agency has ... Reproduction Insurance industry. Today, New Life Agency announces a powerful three-way partnership ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/6/2017)... SAN ANTONIO , Sept. 6, 2017  Robert ... as a Pinnacle Professional Member in recognition of his ... Dr. Szewc serves as a Nephrologist at the practice ... services, emergency medicine, kidney care and hypertension solutions. He ... over 20 years of career experience, as well as ...
(Date:9/5/2017)... , Sept. 5, 2017 Sapheneia and Scannerside ... solution. Scannerside DoseCheck is a third-party Vendor neutral CT ... scanners and allows compliance with current MITA standards. ... XR 29 DoseCheck solution is specifically designed to provide ... of potential radiation doses over a predefined threshold. Scannerside ...
Breaking Medicine Technology: